These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33298615)

  • 21. PD-1-Expressing SARS-CoV-2-Specific CD8
    Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
    Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.
    Wang Z; Yang X; Zhong J; Zhou Y; Tang Z; Zhou H; He J; Mei X; Tang Y; Lin B; Chen Z; McCluskey J; Yang J; Corbett AJ; Ran P
    Nat Commun; 2021 Mar; 12(1):1724. PubMed ID: 33741972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2-reactive IFN-γ-producing CD4
    Olea B; Albert E; Giménez E; Torres I; Amat P; Remigia MJ; Alberola J; Carbonell N; Ferreres J; Blasco ML; Navarro D
    Sci Rep; 2022 Aug; 12(1):14271. PubMed ID: 35995830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired Priming of SARS-CoV-2-Specific Naive CD8
    Gallerani E; Proietto D; Dallan B; Campagnaro M; Pacifico S; Albanese V; Marzola E; Marconi P; Caputo A; Appay V; Gavioli R; Nicoli F
    Front Immunol; 2021; 12():693054. PubMed ID: 34326844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19.
    Fernández-Ruiz M; Olea B; Giménez E; Laguna-Goya R; Trujillo H; Caravaca-Fontán F; Gutiérrez E; López-Medrano F; Remigia MJ; Almendro-Vazquez P; Polanco N; González E; Ruiz-Merlo T; Parra P; San Juan R; Andrés A; Navarro D; Aguado JM
    Transplantation; 2021 Jun; 105(6):1372-1380. PubMed ID: 33729741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4
    Coulon PG; Prakash S; Dhanushkodi NR; Srivastava R; Zayou L; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Nesburn AB; Kuppermann BD; Bahraoui E; Vahed H; Gil D; Jones TM; Ulmer JB; BenMohamed L
    Front Immunol; 2024; 15():1343716. PubMed ID: 38605956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional responsiveness of memory T cells from COVID-19 patients.
    Tavukcuoglu E; Horzum U; Cagkan Inkaya A; Unal S; Esendagli G
    Cell Immunol; 2021 Jul; 365():104363. PubMed ID: 33905951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.
    Ni L; Cheng ML; Feng Y; Zhao H; Liu J; Ye F; Ye Q; Zhu G; Li X; Wang P; Shao J; Deng YQ; Wei P; Chen F; Qin CF; Wang G; Li F; Zeng H; Dong C
    Front Immunol; 2021; 12():603563. PubMed ID: 33603759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-Avidity CD4
    Bacher P; Rosati E; Esser D; Martini GR; Saggau C; Schiminsky E; Dargvainiene J; Schröder I; Wieters I; Khodamoradi Y; Eberhardt F; Vehreschild MJGT; Neb H; Sonntagbauer M; Conrad C; Tran F; Rosenstiel P; Markewitz R; Wandinger KP; Augustin M; Rybniker J; Kochanek M; Leypoldt F; Cornely OA; Koehler P; Franke A; Scheffold A
    Immunity; 2020 Dec; 53(6):1258-1271.e5. PubMed ID: 33296686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
    Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
    Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection.
    Mahalingam SS; Jayaraman S; Arunkumar A; Dudley HM; Anthony DD; Shive CL; Jacobson JM; Pandiyan P
    Front Immunol; 2023; 14():1231087. PubMed ID: 37799713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
    Echeverría G; Guevara Á; Coloma J; Ruiz AM; Vasquez MM; Tejera E; de Waard JH
    Int J Infect Dis; 2021 Apr; 105():21-25. PubMed ID: 33582369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of SARS-CoV-2 variants on the total CD4
    Tarke A; Sidney J; Methot N; Yu ED; Zhang Y; Dan JM; Goodwin B; Rubiro P; Sutherland A; Wang E; Frazier A; Ramirez SI; Rawlings SA; Smith DM; da Silva Antunes R; Peters B; Scheuermann RH; Weiskopf D; Crotty S; Grifoni A; Sette A
    Cell Rep Med; 2021 Jul; 2(7):100355. PubMed ID: 34230917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helminth antigens differentially modulate the activation of CD4
    Adjobimey T; Meyer J; Terkeš V; Parcina M; Hoerauf A
    BMC Med; 2022 Jun; 20(1):241. PubMed ID: 35764965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.
    Dykema AG; Zhang B; Woldemeskel BA; Garliss CC; Cheung LS; Choudhury D; Zhang J; Aparicio L; Bom S; Rashid R; Caushi JX; Hsiue EH; Cascino K; Thompson EA; Kwaa AK; Singh D; Thapa S; Ordonez AA; Pekosz A; D'Alessio FR; Powell JD; Yegnasubramanian S; Zhou S; Pardoll DM; Ji H; Cox AL; Blankson JN; Smith KN
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33830946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report.
    Kongsbak-Wismann M; Al-Jaberi FAH; Schmidt JD; Ghanizada M; Hansen CB; Lopez DV; Woetmann A; Ødum N; Bonefeld CM; Stryhn A; Garred P; Buus S; Geisler C
    Front Immunol; 2021; 12():758154. PubMed ID: 34659264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.